Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2022

Open Access 01-12-2022 | Leg Pain | Study protocol

The effect of an 8-week treatment program using a novel foot neuromuscular electrical stimulator on physical function, leg pain, leg symptoms, and leg blood flow in community-dwelling older adults: a randomized sham-controlled trial

Authors: Binoy Kumaran, Darren Targett, Tim Watson

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Background

Neuromuscular electrical stimulation (NMES) is an established therapy that has been widely used for many decades to improve circulation in the legs. However, studies using NMES devices in an elderly, ambulant, and otherwise apparently healthy population are lacking; this is despite the use of such devices being indicated for lower leg symptoms (such as aches, pain, and cramps) that are frequently seen in older individuals. The main purpose of this study is to evaluate the effect of non-invasive foot NMES (administered using Revitive Medic©) on such symptoms compared to a sham in a 12-week period.

Methods

This is a single-center, single (participant)-blind, parallel-group, randomized, placebo-controlled (sham group), interventional study. Participants will be randomized to 1 of 3 groups (1:1:1) with each study group receiving a different type of foot NMES: Revitive sham; Revitive Medic© Program 1; or Revitive® Program 2. Each participant will be instructed to self-administer the foot NMES device for 30 min twice daily for 8 weeks. During the study, all participants will continue with their normal life, activities, medications, and diet with no restrictions. Following the 8-week NMES treatment program participants will be assessed for Canadian Occupational Performance Measure performance (COPM-P) and satisfaction (COPM-S) scores, lower leg pain, lower leg symptoms (heaviness, tiredness, aching and cramps), and blood flow volume and intensity.

Discussion

Revitive® foot NMES has been proven to increase blood circulation in the legs during use, which may help to relieve symptoms such as pain, heaviness, cramps, and tiredness. When NMES is applied to the plantar surface of the feet it indirectly induces contraction of the calf muscle, activating the musculo-venous pump and thus improving circulation. This study aims to provide data informing on the applicability of foot NMES for the management of leg symptoms that are likely to be indicative of poor circulation in an elderly (> 65 years) community population.

Trial registration

ISRCTN10576209.
Literature
1.
Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144(9):e171–91.CrossRef
2.
Hamburg NM, Creager MA. Pathophysiology of intermittent claudication in peripheral artery disease. Circ J. 2017;81(3):281–9.CrossRef
3.
Besharat S, Grol-Prokopczyk H, Gao S, Feng C, Akwaa F, Gewandter JS. Peripheral edema: A common and persistent health problem for older Americans. PLoS ONE. 2021;16(12):e0260742.CrossRef
4.
Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary. Circulation. 2017;135:e686–725.PubMed
5.
McDermott MM, Metha S, Greenland P. Exertional leg symptoms other than intermittent claudication are common in peripheral artery disease. Arch Intern Med. 2017;159:387–92.CrossRef
6.
7.
Padilla J, Fadel PJ. Prolonged sitting leg vasculopathy: contributing factors and clinical implications. Am J Physiol Heart Circ Physiol. 2017;313(4):H722–8.CrossRef
8.
Morley RL, Sharma A, Horsch AD, Hinchliffe RJ. Peripheral artery disease. BMJ. 2018;360:j5842.CrossRef
9.
McDermott MM. Lower extremity manifestations of peripheral artery disease. The pathophysiologic and functional implications of leg ischemia. Circ Res. 2015;116(9):1540–50.CrossRef
10.
McDermott MM, Applegate WB, Bonds DE, Buford TW, Church T, Espeland MA, et al. Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study. J Am Heart Assoc. 2013;2(6):e000257.CrossRef
11.
Nussbaum EL, Houghton P, Anthony J, Rennie S, Shay BL, Hoens AM. Neuromuscular electrical stimulation for treatment of muscle impairment: Critical review and recommendations for clinical practice. Physiother Can. 2017;69(5):1–76.CrossRef
12.
Doucet BM, Lam A, Griffin L. Neuromuscular electrical stimulation for skeletal muscle function. Yale J Biol Med. 2012;85(2):201–15.PubMedPubMedCentral
13.
Bolter CP, Critz JB. Changes in thoracic and right duct lymph flow and enzyme content during skeletal muscle stimulation. Arch Int Physiol Biochim. 1976;84(1):115–28.PubMed
14.
Faghri PD, Votto JJ, Hovorka CF. Venous hemodynamics of the lower extremities in response to electrical stimulation. Arch Phys Med Rehabil. 1998;79(7):842–8.CrossRef
15.
Kaplan RE, Czyrny JJ, Fung TS, Unsworth JD, Hirsh J. Electrical foot stimulation and implications for the prevention of venous thromboembolic disease. Thromb Haemost. 2002;88(2):200–4.PubMed
16.
Man IOW, Lepar GS, Morrissey MC, Cywinski JK. Effect of neuromuscular electrical stimulation on foot/ankle volume during standing. Med Sci Sports Exerc. 2003;35(4):630–4.CrossRef
17.
Reed BV. Effect of high voltage pulsed electrical stimulation on microvascular permeability to plasma proteins - A possible mechanism in minimising edema. Phys Ther. 1988;68:491–5.CrossRef
18.
Snyder AR, Perotti AL, Lam KC, Bay RC. The influence of high-voltage electrical stimulation on edema formation after acute injury: a systematic review. J Sport Rehabil. 2010;19(4):436–51.CrossRef
19.
Stick, Grau H, Witzleb E. On the edema-preventing effect of the calf muscle pump. Eur J Appl Physiol Occup Physiol. 1989;59(1–2):39–47.CrossRef
20.
Ellul C, Formosa C, Gatt A, Hamadani AA, Armstrong DG. The effectiveness of calf muscle electrostimulation on vascular perfusion and walking capacity in patients living with type 2 diabetes mellitus and peripheral artery disease. Int J Low Extrem Wounds. 2017;16(2):122–8.CrossRef
21.
Williams KJ, Moore HM, Ellis M, Davies AH. Pilot trial of neuromuscular stimulation in human subjects with chronic venous disease. Vasc Health Risk Manag. 2021;17:771–8.CrossRef
22.
Zhang Q, Styf J, Ekstrӧm L, Holm AK. Effects of electrical nerve stimulation on force generation, oxygenation and blood volume in muscles of the immobilized human leg. Scand J Clin Lab Invest. 2014;74(5):369–77.CrossRef
23.
Varatharajan L, Williams K, Moore H, Davies AH. The effect of footplate neuromuscular electrical stimulation on venous and arterial haemodynamics. Phlebology. 2015;30(9):648–50.CrossRef
24.
Babber A, Ravikumar R, Onida S, Lane TRA, Davies AH. Effect of footplate neuromuscular electrical stimulation on functional and quality-of-life parameters in patients with peripheral artery disease: pilot, and subsequent randomized clinical trial. Brit J Surg. 2020;107(4):355–63.CrossRef
25.
Ravikumar R, Williams KJ, Babber A, Lane TRA, Moore HM, Davies AH. Randomised controlled trial: potential benefit of a footplate neuromuscular electrical stimulation device in patients with chronic venous disease. Eur J Vasc Endovasc Surg. 2017;53(1):114–21.CrossRef
26.
Ravikumar R, Lane TR, Babber A, Onida S, Davies AH. A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status. Phlebology. 2021;36(4):290–302.CrossRef
27.
Nielsen TL, Andersen NT, Petersen KS, Polatajko H, Nielsen CV. Intensive client-centred occupational therapy in the home improves older adults’ occupational performance. Results from a Danish randomized controlled trial. Scand J Occup Ther. 2019;26(5):325–42.CrossRef
28.
Tuntland H, Aaslund MK, Espehaug B, Førland O, Kjeken I. Reablement in community-dwelling older adults: a randomised controlled trial. BMC Geriatr. 2015;15(1):145.CrossRef
29.
Eyssen ICJM, Steultjens MPM, Oud TAM, Bolt EM, Maasdam A, Dekker J. Responsiveness of the Canadian Occupational Performance Measure. J Rehab Res Dev. 2011;48:517–28.CrossRef
30.
Law M, Baptiste S, Carswell A, McColl MA, Polatajko H, Pollock N. Canadian Occupational Performance Measure. 5th ed. Ottawa: CAOT Publications ACE; 2014.
31.
Ward G, Jagger C, Harper W. A review of instrumental ADL assessments for use with elderly people. Rev Clin Gerontol. 1998;8(1):65–71.CrossRef
32.
McColl MA, Paterson M, Davies D, Doubt L, Law M. Validity and community utility of the Canadian Occupational Performance Measure. Can J Occup Ther. 2000;67(1):22–30.CrossRef
33.
Dedding C, Cardol M, Eyssen ICJM, Beelen A. Validity of the Canadian Occupational Performance Measure: a client-centred outcome measurement. Clin Rehabil. 2004;18(6):660–7.CrossRef
34.
Enemark Larsen A, Carlsson G. Utility of the Canadian Occupational Performance Measure as an admission and outcome measure in interdisciplinary community-based geriatric rehabilitation. Scand J Occup Ther. 2012;19(2):204–13.CrossRef
35.
Carswell A, McColl MA, Baptiste S, Law M, Polatajko H, Pollock N. The Canadian Occupational Performance Measure: A research and clinical literature review. Can J Occup Ther. 2004;71:210–22.CrossRef
36.
Kumaran B, Herbland A, Watson T. Continuous-mode 448 kHz capacitive resistive monopolar radiofrequency induces greater deep blood flow changes compared to pulsed mode shortwave: a crossover study in healthy adults. Eur J Physiotherapy. 2017;19(3):137–46.CrossRef
37.
Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–91.CrossRef
38.
Suzuki H, Aono S, Inoue S, Imajo Y, Nishida N, Funaba M, et al. Clinically significant changes in pain along the Pain Intensity Numerical Rating Scale in patients with chronic low back pain. PLoS ONE. 2020;15(3):e0229228.CrossRef
39.
Bahreini M, Safaie S, Mirfazaelian H, Jalili M. How much change in pain score does really matter to patients? Am J Emerg Med. 2020;38(8):1641–6.CrossRef
Metadata
Title
The effect of an 8-week treatment program using a novel foot neuromuscular electrical stimulator on physical function, leg pain, leg symptoms, and leg blood flow in community-dwelling older adults: a randomized sham-controlled trial
Authors
Binoy Kumaran
Darren Targett
Tim Watson
Publication date
01-12-2022
Publisher
BioMed Central
Keywords
Leg Pain
Leg Pain
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06828-2

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue

Study protocol

Comparison of Buyang Huanwu granules and Naoxintong capsules in the treatment of stable angina pectoris: rationale and design of a randomized, blinded, multicentre clinical trial

Study protocol

Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial

Study protocol

Effects of Jianpi Lishi Jiedu granules on colorectal adenoma patients after endoscopic treatment: study protocol for a randomized, double-blinded, placebo-controlled clinical trial

Study protocol

Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo controlled trial

Study protocol

Randomized double-blind controlled trial to assess the efficacy of intravenous acetaminophen associated with strong opioids in the treatment of acute pain in adult cancer patients: study protocol

Study protocol

Effect of RG (Coptis root and ginseng) formula in patients with type 2 diabetes mellitus: a study protocol for a randomized controlled and double-blinding trial